Pirfenidone reduces rate of lung decline in idiopathic pulmonary fibrosis
Links shared publicly online about this topic.
- 295total visits
Pirfenidone reduces rate of lung decline in idiopathic pulmonary fibrosis
The CAPACITY study, published Online First and in an upcoming Lancet, shows that pirfenidone reduces the rate of decline of lung function in patients with idiopathic pulmonary fibrosis—a condition of unknown cause affecting hundreds of thousands of patients worldwide that leads to progressive lung ...
View full resource at medicalxpress.com
Tags: Lung, Pulmonary Fibrosis, Pulmonology
Most Recently Shared on May 13, 2011 at 10:30 pm By:
Pirfenidone reduces rate of lung decline in idiopathic pulmonary fibrosis http://tw.medicalxpress.com/224506814
Idiopathic Pulmonary Fibrosis Patients Helped By Pirfenidone, Study Shows | ThirdAge
thirdage.com — “Idiopathic pulmonary fibrosis (IPF) patients can find relief in pirfenidone, which has been shown to help reduce the decline of lung function. Read more at ThirdAge.com.” View full resource at thirdage.com
Most Recently Shared on May 16, 2011 at 9:33 pm By:
Idiopathic Pulmonary Fibrosis Patients Helped By Pirfenidone, Study Shows http://bit.ly/jr35Tj
Advertisement
